PWA
GILD icon

Providence Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Providence Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.14M Buy
15,257
+294
+2% +$41.2K 1.36% 24
2025
Q4 		$1.76M Buy
14,963
+128
+0.9% +$15.6K 1.1% 29
2025
Q3 		$1.75M Buy
14,835
+95
+0.6% +$10.8K 1.1% 29
2025
Q2 		$1.62M Buy
14,740
+239
+2% +$25.4K 1.11% 32
2025
Q1 		$1.61M Buy
14,501
+34
+0.2% +$3.51K 1.22% 30
2024
Q4 		$1.32M Sell
14,467
-55
-0.4% -$4.95K 1% 33
2024
Q3 		$1.28M Buy
14,522
+425
+3% +$32.4K 0.94% 35
2024
Q2 		$981K Buy
14,097
+709
+5% +$47.3K 0.78% 42
2024
Q1 		$964K Sell
13,388
-8,674
-39% -$667K 0.82% 42
2023
Q4 		$4.28M Buy
22,062
+9,921
+82% +$772K 3.87% 4
2023
Q3 		$892K Buy
12,141
+141
+1% +$10.8K 1% 35
2023
Q2 		$927K Buy
12,000
+460
+4% +$36.7K 1.03% 32
2023
Q1 		$970K Sell
11,540
-1,190
-9% -$98.6K 0.72% 43
2022
Q4 		$1.09M Buy
12,730
+217
+2% +$17.2K 0.81% 41
2022
Q3 		$1.04M Sell
12,513
-10
-0.1% -$631 0.78% 42
2022
Q2 		$780K Buy
12,523
+1,270
+11% +$78.6K 0.56% 55
2022
Q1 		$671K Buy
11,253
+338
+3% +$21.6K 0.43% 65
2021
Q4 		$786K Buy
10,915
+1,405
+15% +$96.8K 0.49% 57
2021
Q3 		$651K Buy
+9,510
New +$668K 0.45% 64

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Providence Wealth Advisors's GILD Position: Q1 2026 in Review

Providence Wealth Advisors increased its Gilead Sciences (GILD) stake by 2% in Q1 2026, buying an estimated $41.2K and bringing the position to 15,257 shares worth $2.14M. The position accounts for 1.36% of the portfolio, ranked #24.

Providence Wealth Advisors first reported a position in GILD in Q3 2021 and has held it in 19 quarters since. The position peaked at $4.28M in Q4 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Providence Wealth Advisors held 15,257 shares of Gilead Sciences worth $2.14M as of Q1 2026.
  • Providence Wealth Advisors bought 294 Gilead Sciences shares in Q1 2026, an estimated $41.2K.
  • Gilead Sciences made up 1.36% of Providence Wealth Advisors's portfolio in Q1 2026, its #24 holding.
  • Providence Wealth Advisors first reported a position in Gilead Sciences in Q3 2021 and has held it in 19 quarters since.
  • Providence Wealth Advisors's Gilead Sciences position peaked at $4.28M in Q4 2023.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Providence Wealth Advisors's 13F filing for Q1 2026, filed 5 May 2026.